Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation

Inflammation is ubiquitous in the body, triggering desirable immune response to defend against dangerous signals or instigating undesirable damage to cells and tissues to cause disease. Nanomedicine holds exciting potential in modulating inflammation. In particular, cell membranes derived from cells involved in the inflammatory process may be used to coat nanotherapeutics for effective targeted delivery to inflammatory tissues. Herein, the recent progress of rationally engineering cell membrane‐based nanotherapeutics for inflammation therapy is highlighted, and the challenges and opportunities presented in realizing the full potential of cell‐membrane coating in targeting and manipulating the inflammatory microenvironment are discussed. Recent advances of rationally engineering cell membrane‐based nanotherapeutics for inflammation therapy are summarized and the state‐of‐the‐art cell membrane engineering, extraction, and cloaking technologies are introduced. The challenges and opportunities of such bioinspired nanomedicine allow for the realization of the full potential of cell‐membrane coating in targeting and manipulating the inflammatory microenvironment.